{"article_title": "Specialty Pharmacy Boom Will Continue And CVS Health To Be a Major Beneficiary", "article_keywords": ["major", "cvs", "specialty", "beneficiary", "continue", "health", "boom", "pharmacy"], "article_url": "http://www.forbes.com/sites/greatspeculations/2015/09/21/specialty-pharmacy-boom-will-continue-and-cvs-health-to-be-a-major-beneficiary/", "article_text": "", "article_metadata": {"prerender-status-code": "{{meta.code}}", "author": "Great Speculations", "og": {"site_name": "Forbes", "description": "In the U.S., the Affordable Care Act, which is expected to bring in more people under insurance coverage, has created new opportunities in insurance and pharmacy benefit management. At the same time, drug manufacturers continue to come up with more effective ways of treating the rarest of conditions (called specialty drugs), driving drug spending upwards. The latter is what we will focus on in this article, while also discussing why we believe CVS Health , among its competitors, is best placed to capitalize on these trends.", "title": "Specialty Pharmacy Boom Will Continue And CVS Health To Be a Major Beneficiary", "url": "http://www.forbes.com/sites/greatspeculations/2015/09/21/specialty-pharmacy-boom-will-continue-and-cvs-health-to-be-a-major-beneficiary/", "image": "http://wp-uploads-trefis.s3.amazonaws.com/articles/wp-content/uploads/2015/09/Drug-Trend.jpg", "updated_time": "2015-09-22T14:47:33-04:00", "type": "article"}, "twitter": {"image": "http://wp-uploads-trefis.s3.amazonaws.com/articles/wp-content/uploads/2015/09/Drug-Trend.jpg", "description": "In the U.S., the Affordable Care Act, which is expected to bring in more people under insurance coverage, has created new opportunities in insurance and pharmacy benefit management. At the same time, drug manufacturers continue to come up with more effective ways of treating the rarest of conditions (called specialty drugs), driving drug spending upwards. The latter is what we will focus on in this article, while also discussing why we believe CVS Health , among its competitors, is best placed to capitalize on these trends.", "site": "@forbes", "card": "summary_large_image", "title": "Specialty Pharmacy Boom Will Continue And CVS Health To Be a Major Beneficiary"}, "apple-itunes-app": "app-id=588647136", "fb": {"app_id": 123694841080850}, "keywords": "Investing,Markets,Stocks", "article": {"publisher": "https://www.facebook.com/forbes", "section_url": "http://www.forbes.com/investing", "section": "Investing", "modified": "2015-09-22", "published": "2015-09-21", "id": "blogAndPostId/blog/post/25-154941"}, "news_keywords": "Investing,Markets,Stocks", "viewport": "width=device-width,initial-scale=1,maximum-scale=1,user-scalable=no", "description": "In the U.S., the Affordable Care Act, which is expected to bring in more people under insurance coverage, has created new opportunities in insurance and pharmacy benefit management. At the same time, drug manufacturers continue to come up with more effective ways of treating the rarest of conditions (called specialty drugs), driving drug spending upwards. The latter is what we will focus on in this article, while also discussing why we believe CVS Health , among its competitors, is best placed to capitalize on these trends."}, "_id": "\"57477af46914bd0286fd894b\"", "article_summary": ""}